Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jintong Du

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Cancer|January 10, 2022
PTPRO is a therapeutic target and correlated with immune infiltrates in pancreatic cancerXuben Hou, Jintong Du, Hao Fang
Current Drug Targets|November 6, 2013
Lymphoid-specific tyrosine phosphatase (Lyp): a potential drug target for treatment of autoimmune diseasesJintong Du, Yu Qiao, Lele Sun, et al.
Protein and Peptide Letters|December 22, 2010
3D-QSAR study on a series of Bcl-2 protein inhibitors using comparative molecular field analysisXuben Hou, Jintong Du, Hao Fang, et al.
Expert Opinion on Investigational Drugs|November 13, 2020
Recent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapyHanzhi Liang, Jintong Du, Reham M Elhassan, et al.
Journal of Chemical Information and Modeling|December 19, 2012
How to improve docking accuracy of AutoDock4.2: a case study using different electrostatic potentialsXuben Hou, Jintong Du, Jian Zhang, et al.
Future Medicinal Chemistry|May 14, 2020
Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibitorsJintong Du, Lulu Liu, Bo Liu, et al.
Journal of Chemical Information and Modeling|March 11, 2015
Enhancing the Sensitivity of Pharmacophore-Based Virtual Screening by Incorporating Customized ZBG Features: A Case Study Using Histone Deacetylase 8Xuben Hou, Jintong Du, Renshuai Liu, et al.
Frontiers in Pharmacology|May 20, 2022
Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast CancerHanzhi Liang, Yue Zhu, Zhiyuan Zhao, et al.
Bioorganic & Medicinal Chemistry|July 22, 2020
An in silico mechanistic insight into HDAC8 activation facilitates the discovery of new small-molecule activatorsJintong Du, Wen Li, Bo Liu, et al.
European Journal of Medicinal Chemistry|October 11, 2025
Discovery of benzimidazole-based Mcl-1 inhibitors via AlphaShape-enabled virtual screeningYiming Nie, Jintong Du, Xin Yan, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Cancer|January 10, 2022
PTPRO is a therapeutic target and correlated with immune infiltrates in pancreatic cancerXuben Hou, Jintong Du, Hao Fang
Current Drug Targets|November 6, 2013
Lymphoid-specific tyrosine phosphatase (Lyp): a potential drug target for treatment of autoimmune diseasesJintong Du, Yu Qiao, Lele Sun, et al.
Protein and Peptide Letters|December 22, 2010
3D-QSAR study on a series of Bcl-2 protein inhibitors using comparative molecular field analysisXuben Hou, Jintong Du, Hao Fang, et al.
Expert Opinion on Investigational Drugs|November 13, 2020
Recent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapyHanzhi Liang, Jintong Du, Reham M Elhassan, et al.
Journal of Chemical Information and Modeling|December 19, 2012
How to improve docking accuracy of AutoDock4.2: a case study using different electrostatic potentialsXuben Hou, Jintong Du, Jian Zhang, et al.
Future Medicinal Chemistry|May 14, 2020
Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibitorsJintong Du, Lulu Liu, Bo Liu, et al.
Journal of Chemical Information and Modeling|March 11, 2015
Enhancing the Sensitivity of Pharmacophore-Based Virtual Screening by Incorporating Customized ZBG Features: A Case Study Using Histone Deacetylase 8Xuben Hou, Jintong Du, Renshuai Liu, et al.
Frontiers in Pharmacology|May 20, 2022
Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast CancerHanzhi Liang, Yue Zhu, Zhiyuan Zhao, et al.
Bioorganic & Medicinal Chemistry|July 22, 2020
An in silico mechanistic insight into HDAC8 activation facilitates the discovery of new small-molecule activatorsJintong Du, Wen Li, Bo Liu, et al.
European Journal of Medicinal Chemistry|October 11, 2025
Discovery of benzimidazole-based Mcl-1 inhibitors via AlphaShape-enabled virtual screeningYiming Nie, Jintong Du, Xin Yan, et al.
Pageof 2